The stock of Medical Facilities Corp (TSE:DR) is a huge mover today! About 34,019 shares traded hands. Medical Facilities Corp (TSE:DR) has risen 27.01% since April 1, 2016 and is uptrending. It has outperformed by 25.06% the S&P500.
The move comes after 7 months positive chart setup for the $636.99 million company. It was reported on Nov, 7 by Barchart.com. We have $26.50 PT which if reached, will make TSE:DR worth $165.62 million more.
Medical Facilities Corp (TSE:DR) Ratings Coverage
Out of 2 analysts covering Medical Facilities Corp (TSE:DR), 2 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. $25 is the highest target while $17.50 is the lowest. The $19.88 average target is -5.47% below today’s ($21.03) stock price. Medical Facilities Corp has been the topic of 4 analyst reports since August 14, 2015 according to StockzIntelligence Inc. The stock of Medical Facilities Corp (TSE:DR) has “Buy” rating given on Friday, October 7 by TD Securities. The stock of Medical Facilities Corp (TSE:DR) has “Sector Perform” rating given on Monday, August 17 by National Bank Canada.
Another recent and important Medical Facilities Corp (TSE:DR) news was published by Reuters.com which published an article titled: “BRIEF-Medical Facilities Corp signs to buy Indiana physician-owned hospita…” on July 15, 2016.
Medical Facilities Corporation is a Canada company, which owns interests in over six entities , approximately five of which either own a specialty surgical hospital (SSH) or an ambulatory surgery center (ASC). The company has a market cap of $636.99 million. The Company’s Centers offer facilities, such as staff, surgical materials and supplies, and other support necessary for scheduled surgical, pain management, imaging and diagnostic procedures. It currently has negative earnings. The Centers focus on clinical specialties, such as orthopedic, neurosurgery, pain management and other non-emergency elective procedures.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.